Blog
RSS FeedPosted by Michael Wonder on 19 Sep 2019
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
18 September 2019 - In this study, the investigators examined the characteristics of randomised controlled trials that supported approval of cancer ...
Posted by Michael Wonder on 19 Sep 2019
5 people setting EU drug prices
19 September 2019 - Politic’s guide to the policy makers debating how to calculate the cost of cures. ...
Posted by Michael Wonder on 19 Sep 2019
FDA continues to take steps to fulfil its commitment to strengthen and modernise the 510(k) medical device program
19 September 2019 - The U.S. FDA today announced that, as a first step toward implementation of the recently established Safety ...
Posted by Michael Wonder on 19 Sep 2019
McConnell warns Pelosi's drug pricing plan is DOA
19 September 2019 - Senate Republicans are warning Speaker Nancy Pelosi that her much-anticipated drug pricing plan is dead and ...
Posted by Michael Wonder on 19 Sep 2019
Novartis has submitted application to EMA for approval of Cosentyx in nr-axSpA, which would be the fourth indication
17 September 2019 - 52-week data from the PREVENT study, to support FDA submission, are expected later in the year. ...
Posted by Michael Wonder on 19 Sep 2019
Pelosi’s drug plan would let U.S. negotiate prices of 250 medications
19 September 2019 - Speaker Nancy Pelosi on Thursday released her long-awaited plan to curb soaring prices of prescription drugs, ...
Posted by Michael Wonder on 19 Sep 2019
Flawed evidence underpins approval of new cancer drugs
18 September 2019 - We must raise the bar to ensure real benefits for patients ...
Posted by Michael Wonder on 19 Sep 2019
Why prescription drugs cost so much more in America
19 September 2019 - The US spends more per capita on medication than anywhere else in the world. It’s a key ...
Posted by Michael Wonder on 19 Sep 2019
Electronic prescribing
19 September 2019 - Electronic Prescribing will provide an option for prescribers (including doctors, dentists, optometrists, midwives and nurse practitioners), and ...
Posted by Michael Wonder on 19 Sep 2019
FDA grants fast track designation for SPI-1005 in the treatment of Meniere's disease
18 September 2019 - Sound Pharmaceuticals is pleased to announce that the FDA's Division of Neurology Products has granted its request ...
Posted by Michael Wonder on 18 Sep 2019
Xanax still being overprescribed despite policy changes
19 September 2019 - Patients are still being prescribed hundreds of Xanax tablets a year despite a cut in government ...
Posted by Michael Wonder on 18 Sep 2019
Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes
18 September 2019 - As controversy continues over prescription drug pricing, a new study finds that Medicare Part D spent ...
Posted by Michael Wonder on 18 Sep 2019
Baby Pia: almost 1 million Belgians pay for life-saving drug
18 September 2019 - More than 950,000 Belgians have responded to a couple seeking €1.9m ($2m; £1.7m) to cover the ...
Posted by Michael Wonder on 18 Sep 2019
Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications
16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...
Posted by Michael Wonder on 18 Sep 2019
Health insurance that doesn’t cover the bills has flooded the market under Trump
18 September 2019 - The administration’s moves to weaken the Affordable Care Act have taken hold, and companies are cashing in. ...